Next Article in Journal
Rabbit Hemorrhagic Disease Virus Detected in Pico, Azores, Portugal, Revealed a Unique Endemic Strain with More Than 17 Years of Independent Evolution
Next Article in Special Issue
Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names
Previous Article in Journal
Phages Preying on Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis: Past, Present and Future
Previous Article in Special Issue
Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
Article Menu

Export Article

Open AccessMeeting Report
Viruses 2014, 6(7), 2673-2697; doi:10.3390/v6072673

Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

1
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
2
Medical Countermeasure Systems, Department of Defense, Ft. Detrick, Frederick, MD 21702, USA
3
Biodefense Advanced Research and Development Authority, Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC 20201, USA
4
Medical Countermeasure Systems, Department of Defense, Fort Belvoir, VA 22060, USA
*
Author to whom correspondence should be addressed.
Received: 22 April 2014 / Revised: 1 July 2014 / Accepted: 1 July 2014 / Published: 9 July 2014
(This article belongs to the Collection Advances in Ebolavirus, Marburgvirus, and Cuevavirus Research)
View Full-Text   |   Download PDF [582 KB, uploaded 12 May 2015]

Abstract

On August 22–23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U.S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field. View Full-Text
Keywords: Ebola; Sudan; ebolavirus; Marburg virus; marburgvirus; Filoviridae; filovirus medical countermeasures; Filovirus Animal Non-clinical Group; FANG Ebola; Sudan; ebolavirus; Marburg virus; marburgvirus; Filoviridae; filovirus medical countermeasures; Filovirus Animal Non-clinical Group; FANG
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Hirschberg, R.; Ward, L.A.; Kilgore, N.; Kurnat, R.; Schiltz, H.; Albrecht, M.T.; Christopher, G.W.; Nuzum, E. Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop. Viruses 2014, 6, 2673-2697.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top